Literature DB >> 20047033

The role of nanobiotechnology in drug discovery.

Kewal K Jain1.   

Abstract

The potential applications of nanotechnology in life sciences, particularly nanobiotechnology, include those for drug discovery. This chapter shows how several of the nanotechnologies including nanoparticles and various nanodevices such as nanobiosensors and nanobiochips are being used to improve drug discovery. Nanoscale assays using nanoliter volumes contribute to cost saving. Some nanosubstances such as fullerenes are drug candidates. There are some safety concerns about the in vivo use of nanoparticles that are being investigated. However, future prospects for applications in healthcare of drugs discovered through nanotechnology and their role in the development of personalized medicine appear to be excellent.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20047033     DOI: 10.1007/978-1-4419-1132-2_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  4 in total

Review 1.  Gold nanoparticles in cancer therapy.

Authors:  Zhao-Zhin Joanna Lim; Jia-En Jasmine Li; Cheng-Teng Ng; Lin-Yue Lanry Yung; Boon-Huat Bay
Journal:  Acta Pharmacol Sin       Date:  2011-07-11       Impact factor: 6.150

2.  A bioanalytical platform for simultaneous detection and quantification of biological toxins.

Authors:  Oliver G Weingart; Hui Gao; François Crevoisier; Friedrich Heitger; Marc-André Avondet; Hans Sigrist
Journal:  Sensors (Basel)       Date:  2012-02-21       Impact factor: 3.576

3.  An investigation on the cytotoxicity and caspase-mediated apoptotic effect of biologically synthesized gold nanoparticles using Cardiospermum halicacabum on AGS gastric carcinoma cells.

Authors:  Chunfeng Li; Yimin Wang; Hongfeng Zhang; Man Li; Ziyu Zhu; Yingwei Xue
Journal:  Int J Nanomedicine       Date:  2019-02-05

Review 4.  Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma?

Authors:  Brenda Auffinger; Ramin Morshed; Alex Tobias; Yu Cheng; Atique U Ahmed; Maciej S Lesniak
Journal:  Oncotarget       Date:  2013-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.